Human IGFBP-1 antiserum is a polyclonal antiserum raised against a
    synthetic peptide corresponding to amino acids 136-147 (Zapf, J. (1995)
    Eur. J. Endocrinol. 132, 645-654) of human IGFBP-1. This antiserum is
    suitable for use in ELISA and Western blotting and should find
    application in immunohistochemistry.

    Source:
                         The antiserum was obtained from rabbits immunized
                         against a synthetic peptide corresponding to amino
                         acids 136-147 (Zapf, J. 1995) of human IGFBP-1.
     Quantity:
                         100 µl of serum
     Appearance:
                         White powder
     Specificity:
                         No crossreactivity is found with human IGFBP-2,
                         IGFBP-3 or IGFBP-4.
     Titre:
                         Can be used at a dilution of 1/4,000 in ELISA.
                         Half-maximal inhibition (ED50) is produced by 28 ng
                         hIGFBP-1 / 100µl. For Western blotting use a dilution
                         of 1/1,000.
     Reconstitution:
                         Dissolve in 100 µl sterile water. Dilute in a suitable
                         buffer solution appropriate for the desired application.
     Storage/Stability:
                         At least 2 years at 2 -4°C (lyophilised). After
                         reconstitution, aliquot and store at -20°C. Avoid
                         repeated freezing and thawing.
 

 Datasheet for Anti-Human IGFBP-1 Antiserum, Polyclonal (Rabbit)